| Caption | Panel discussion. Left - right: Lucia Erniawati, Head of Market Access & Corporate Affairs, PT Roche Indonesia (Moderator); Dr. dr. Nugroho Prayogo, SpPD-KHOM, Investigator SafeHER Indonesia; Zr. Musrini, S.ST, Oncology Specialist Nurse; Dr. Diah Ayu Puspandari Apt. M.Kes, MBA, Center for Health Financing Policy and Insurance Management (KPMAK) |
| Source | Roche Indonesia |
| Download | |
| Related Press Releases Links |
Roche's New Timesaving Formulation of trastuzumab Approved in Indonesia for the Treatment of HER2-Positive Breast Cancer Trastuzumab Subkutan: Formulasi Baru yang Menghemat Waktu Perawatan Kanker Payudara HER2-Positif dari Roche Kini Hadir di Indonesia. |